Showing results (11-20 of 76) with videos related to
Sort By:
Pageof 8
Infection and Immunity|August 5, 2009
Plasmodium falciparum-specific cellular immune responses after immunization with the RTS,S/AS02D candidate malaria vaccine in infants living in an area of high endemicity in MozambiqueArnoldo Barbosa, Denise Naniche, John J Aponte, et al.Malaria Journal|August 6, 2011
Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in AfricaAmanda Leach, Johan Vekemans, Marc Lievens, et al.BMJ Open|March 11, 2014
Acute Exacerbation and Respiratory InfectionS in COPD (AERIS): protocol for a prospective, observational cohort studySimon Bourne, Catherine Cohet, Viktoriya Kim, et al.Frontiers in Immunology|June 8, 2017
Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical TrialRobert A van den Berg, Margherita Coccia, W Ripley Ballou, et al.Human Vaccines|July 10, 2009
The candidate tuberculosis vaccine Mtb72F/AS02A: Tolerability and immunogenicity in humansKenneth Von Eschen, Royce Morrison, Madeleine Braun, et al.The Journal of Infectious Diseases|January 19, 2010
Expression of genes associated with immunoproteasome processing of major histocompatibility complex peptides is indicative of protection with adjuvanted RTS,S malaria vaccineMaryanne T Vahey, Zhining Wang, Kent E Kester, et al.Plos One|April 15, 2009
Insights into long-lasting protection induced by RTS,S/AS02A malaria vaccine: further results from a phase IIb trial in Mozambican childrenCaterina Guinovart, John J Aponte, Jahit Sacarlal, et al.Clinical and Vaccine Immunology : CVI|September 24, 2010
Evaluation of the safety and immunogenicity of two antigen concentrations of the Mtb72F/AS02(A) candidate tuberculosis vaccine in purified protein derivative-negative adultsIsabel Leroux-Roels, Geert Leroux-Roels, Opokua Ofori-Anyinam, et al.Scientific Reports|May 25, 2021
Ultra-low dose immunization and multi-component vaccination strategies enhance protection against malaria in miceKatharine A Collins, Florian Brod, Rebecca Snaith, et al.Tuberculosis (Edinburgh, Scotland)|December 11, 2012
The candidate tuberculosis vaccine Mtb72F/AS02 in PPD positive adults: a randomized controlled phase I/II studyFrançois Spertini, Régine Audran, Floriana Lurati, et al.Pageof 8